Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.

Continue ReadingProf. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"

Continue ReadingHarm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

Smoking, experts: “Alternative products reduce the harm and help those who wants to quit smoking”

According to Giovanni Li Volti, director of CoEHAR, the Center of Excellence for the Acceleration of Harm Reduction in Catania, "To date, the results that have emerged confirm that there are no longer any doubts: electronic cigarettes are more than 95% less harmful than conventional cigarettes”

Continue ReadingSmoking, experts: “Alternative products reduce the harm and help those who wants to quit smoking”

ECIG: a new study by CoEHAR screens different lab tests to evaluate the potential risk

The aim of the study is to investigate different in vitro toxicity methods for the assessment of ENDs toxicity. According to the Italian researchers, the most used assay, the neutral red uptake, should be combined with different tools (enlisted in the study) to better identifies the toxicity of the products and can avoid approximate and incorrect evaluation

Continue ReadingECIG: a new study by CoEHAR screens different lab tests to evaluate the potential risk